These findings suggest that the phytochemical sesamol and its target, the Nrf2 activation, in adipocytes might be useful tools for developing treatments for obesity and related metabolic diseases. This evidence concerns the gene NFE2L2 and obesity due to melanocortin 4 receptor deficiency.